Research never stops

Top Story

Evotec and Merck enter into agreements to collaborate on target discovery technologies

Hamburg, Germany, 30 November 2016: Evotec AG today announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine Merck's portfolio of genome editing technologies with Evotec's versatile screening platforms and disease expertise.

- read more

Evotec AG reports results of first nine months of 2016

Hamburg, Germany, 10 November 2016: Evotec AG today reported financial results and corporate updates for the first nine months of 2016.

- read more

Evotec and Oxford create novel Partnership called 'LAB282'

Hamburg, Germany, 10 November 2016: Evotec AG today announced a novel strategic partnership with the University of Oxford, Oxford University Innovation Ltd, OUI and Oxford Sciences Innovation, OSI aimed at accelerating the translation of basic biomedical research from Oxford into new therapeutics.

- read more
loading weather report
Loading weather report...


Company Presentation December

Building integrated and high-value drug discovery alliances
2016-12_Evotec_Company presentation_December